Saturday, June 13, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1073 of 1,261
  1. US 7297523

    Human elongase genes and uses thereof

    Xenon Pharmaceuticals Inc. · Granted Nov 20, 2007 · Expires Nov 15, 2027

    granted
  2. US 7294475

    Gene and use thereof

    Takeda Chemical Industries Ltd. · Granted Nov 13, 2007 · Expires Nov 8, 2027

    granted
  3. US 7294496

    Cloned human lysophospholipase

    The Regents of the University of California · Granted Nov 13, 2007 · Expires Nov 8, 2027

    granted
  4. US 7294480

    High throughput screening assays using fatty acid synthetic enzymes

    Xenon Pharmaceuticals Inc. · Granted Nov 13, 2007 · Expires Nov 8, 2027

    granted
  5. US 7294735

    Purification of cinacalcet

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 13, 2007 · Expires Nov 8, 2027

    granted
  6. US 7294344

    Sustained-release preparation for AII antagonist, production and use thereof

    Takeda Pharmaceutical Company Limited · Granted Nov 13, 2007 · Expires Nov 8, 2027

    granted
  7. US 7294699

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Nov 13, 2007 · Expires Nov 8, 2027

    granted
  8. US 7294687

    Parenteral formulations of a peptide for the treatment of systemic lupus erythematosus

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 13, 2007 · Expires Nov 8, 2027

    granted
  9. IT MI20070164

    CEROTTO TRANSDERMICO

    AXXONIS PHARMA AG · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted
  10. US 7291699

    Product and methods for diagnosis and therapy for cardiac and skeletal muscle disorders

    The Regents of the University of Colorado · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted
  11. US 7291603

    Nucleoside compounds and their use for treating cancer and diseases associated with somatic mutations

    PTC THERAPEUTICS, INC. · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted
  12. US 7291611

    Benzimidazolidinone derivatives as muscarinic agents

    ACADIA Pharmaceuticals Inc. · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted
  13. US 7291614

    Processes for the preparation of linezolid intermediate

    TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted
  14. US 7291336

    Compositions and methods for enhancing immune responses mediated by antigen-presenting cells

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted
  15. US 7291348

    Compositions and methods for biodegradable microspheres as carriers of bioactive substances

    The Board of Regents of the University of Texas System · Granted Nov 6, 2007 · Expires Nov 1, 2027

    granted
  16. AU 2007242062

    Pharmaceutical compositions of oxcarbazepine with a median particle size of 15 to 30 microns

    ALPHAPHARM PTY LTD [AU] · Granted Nov 1, 2007 · Expires Oct 27, 2027

    granted
  17. CA 2648495

    FORMULATIONS A LIBERATION CONTROLEE QUI COMPRENNENT UNE OU PLUSIEURS UNITES DISCRETES NON ENROBEES ET UNE MATRICE A LIBERATION RETARDEE

    ALPHAPHARM PTY LTD [AU] · Granted Nov 1, 2007 · Expires Oct 27, 2027

    granted
  18. US 7288671

    Interleukin-1 and tumor necrosis factor-α modulators, synthesis of said modulators and their enantiomers and methods of using said modulators

    The Regents of the University of California · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted
  19. US 7288624

    Inhibitors of interleukin-1β converting enzyme

    Vertex Pharmaceuticals Incorporated · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted
  20. US 7288254

    Use of immunotoxins to induce immune tolerance to pancreatic islet transplantation

    The United States of America as Represented by the Secretary Department of Health and Human Services (NIH) · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted
  21. US 7288654

    Fused-ring pyridine derivative, process for producing the same, and use

    Takeda Pharmaceutical Company Limited · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted
  22. US 7288646

    USPA2 nucleic acid of Moraxella catarrhalis

    The Board of Regents of the University of Texas System · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted
  23. US 7288657

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted
  24. US 7288608

    Degradable thiol-ene polymers

    The Regents of the University of Colorado · Granted Oct 30, 2007 · Expires Oct 25, 2027

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.